Karen M. Anderson - 01 Dec 2022 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief People Officer
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
01 Dec 2022
Net transactions value
$0
Form type
4
Filing time
05 Dec 2022, 15:42:23 UTC
Previous filing
05 Dec 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTA Share Option (right to buy) Award $0 +300,000 $0.000000 300,000 01 Dec 2022 Ordinary Shares 300,000 $4.01 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to such option shall vest and become exercisable on December 1, 2023 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.